Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications - Candlesense

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending.